PharmaLink has secured a growth investment from WestView Capital Partners to enhance its pharmaceutical reverse logistics capabilities amid increasing market demands.

Target Information

PharmaLink, headquartered in Largo, Florida, is a leading pharmaceutical reverse logistics platform that operates as a centralized hub for the processing of unsaleable, expired, and recalled pharmaceutical products. The company provides essential support to pharmacies, hospitals, wholesalers, and manufacturers by facilitating the efficient management of product returns and refunds while ensuring compliance with federal and state regulations. PharmaLink’s extensive range of services includes product pickup and shipping, return and recall processing, credit reporting, reconciliation, regulatory documentation, and eco-friendly disposal.

Recently, PharmaLink announced the expansion of its flagship operations center by an additional 50,000 square feet, effectively doubling its processing capacity. This expansion is a response to increased demand across the pharmaceutical supply chain and is set to drive the implementation of advanced automation solutions, enhancing compliance, efficiency, and sustainability in its operations.

Industry Overview

The pharmaceutical reverse logistics industry is experiencing a significant transformation, shaped by the growing need for efficient product lifecycle management. In the United States, the demand for services that handle unsaleable or expired drugs has sur